CSL Licenses Arcturus mRNA Technology, But COVID-19 Vaccine Remains Uncertain

 
• By Alaric DeArment
  
Arcturus and CSL signed a deal around mRNA vaccine technology • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business